Lebanon National Drugs Database
This section represents the official information about the pharmaceutical products registered & marketed at the Ministry of Public Health
You can search in the form below for information related to drugs including Subsidy percentage
Drugs code ending with "/945" are subject to the Resolution 945/1 date 3/10/2022
Drugs code ending with "/945" are subject to the Resolution 945/1 date 3/10/2022
| ATC | Name | B/G | Ingredients | Dosage | Form | Price |
|---|---|---|---|---|---|---|
| L01EA01 | IMATINIB SPC | G | Imatinib - 100mg | 100mg | Tablet, film coated | 29473180.56 |
| L01EA01 | SAGITTA | G | Imatinib - 100mg | 100mg | Capsule, hard | 25170264 |
| L01EA01 | GLIMATINIB BENTA 400 | G | Imatinib (mesylate) - 400mg | 400mg | Tablet, film coated | |
| L01EA01 | CEMIVIL | G | Imatinib - 400mg | 400mg | Tablet, film coated | 41106321.301694 |
| L01DC01 | BLEOCIN | B | Bleomycin (sulfate) - 15U | 15U | Injectable lyophilised powder for solution | 2109832.725 |
| L01DC01 | BLEO-CELL | G | Bleomycin (sulfate) - 15mg | 15mg | Injectable powder for solution | 3817856.5425 |
| L01DB07 | MITOXANTRON EBEWE | G | Mitoxantrone - 20mg/10ml | 20mg/10ml | Injectable concentrated solution | 11064119.842125 |
| L01DB06 | ZAVEDOS | B | Idarubicin HCl - 10mg | 10mg | Injectable freeze dried material | 12071013.288075 |
| L01DB03 | EPIRUBICINE VIATRIS 2MG/ML | G | Epirubicin HCl - 10mg/5ml | 10mg/5ml | Injectable solution | 855212.434076 |
| L01DB03 | EPIRUBICINE VIATRIS 2MG/ML | G | Epirubicin HCl - 50mg/25ml | 50mg/25ml | Injectable solution | 3914241.525194 |
| L01DB02 | CERUBIDINE | B | Daunorubicin (HCl) - 20mg | 20mg | Injectable powder for solution | 10943136.5211 |
| L01DB01 | CAELYX | B | Doxorubicin HCl pegylated liposomes - 20mg/10ml | 20mg/10ml | Injectable concentrated solution | |
| L01DB01 | DOXORUBICINE EBEWE | G | Doxorubicin HCl - 10mg/5ml | 10mg/5ml | Injectable concentrated solution | 428685.7575 |
| L01DB01 | DOXO-CELL | G | Doxorubicin HCl - 50mg/25ml | 50mg/25ml | Injectable solution | 1794029.7375 |
| L01DB01 | DOXORUBICINA PHARMINICIO | G | Doxorubicin HCl - 50mg/25ml | 50mg/25ml | Injectable concentrate for solution | 2015763.75 |
| L01DB01 | DOXORUBICINE EBEWE | G | Doxorubicin HCl - 2mg/ml | 50mg/25ml | Injectable concentrated solution | 1804780.4775 |
Download the new version of the MOPH app
for the latest updates on Coronavirus.
The new version of the MOPH APP will provide you with all the reliable information on COVID-19 with ongoing update of the confirmed cases and data. If you are showing any symptoms, the “Symptoms Checker” will be your self-help guide to assess them.
